Benchmark (LON:BMK) Stock Price Down 13.1% - Here's Why

Key Points

• Benchmark Holdings plc shares fell by 13.1% on Tuesday, trading at GBX 19.29 ($0.26), marking an 83% decline in transaction volume from the average.
• The company reported a negative earnings per share (EPS) of GBX (1.77) (($0.02)) for the last quarter, with a negative return on equity of 16.05% and a negative net margin of 43.67%.
• Benchmark has a current market capitalization of £142.95 million and is focused on developing sustainable aquaculture solutions to improve producers' profitability.

Benchmark Holdings plc (LON:BMK - Get Free Report) was down 13.1% on Tuesday . The company traded as low as GBX 19.29 ($0.26) and last traded at GBX 19.29 ($0.26). Approximately 48,998 shares were traded during trading, a decline of 83% from the average daily volume of 296,043 shares. The stock had previously closed at GBX 22.20 ($0.30).

Benchmark Price Performance

The company's fifty day moving average is GBX 23.65 and its 200 day moving average is GBX 24.08. The firm has a market cap of £144.55 million, a price-to-earnings ratio of -3.65, a PEG ratio of -19.62 and a beta of 0.69. The company has a quick ratio of 1.41, a current ratio of 1.73 and a debt-to-equity ratio of 33.02.

Benchmark (LON:BMK - Get Free Report) last announced its earnings results on Thursday, June 12th. The company reported GBX (1.77) (($0.02)) EPS for the quarter. Benchmark had a negative return on equity of 16.05% and a negative net margin of 43.67%. On average, equities research analysts predict that Benchmark Holdings plc will post 0.9566873 EPS for the current year.

About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.We bring together biology and technology to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), diets and probiotics and sea lice treatments.